Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), the major primary liver malignancy, is one of the leading causes of cancer-related deaths globally. Initiation and progression of HCC is considered a multi-step process. Genetics and epigenetics alterations contribute to the tumorigenesis of HCC, but the precise molecular events underlying HCC formation remain only partially understood. Recently, with the advancement of high-throughput biology techniques, bioinformatics analysis using integrated analytic approaches have been applied to multiple data platforms which contain large sets of clinically annotated HCC cases (eg. ATCC, GEPIA, UALCAN, TCGA, ONCOMINE, LinkedOmics, Kaplan-Meier Plotter, OncoLnc). Meanwhile, there has been an unprecedented expansion in the field of nanomedicine and immune-oncology with the development of new agents for the diagnosis and treatment of HCC. These valuable advances have given us a comprehensive and better understanding of HCC, and led to a number of clinical trials in HCC.

This Research Topic aims to make substantial advances in our knowledge of hepatocellular carcinoma by publishing outstanding research. We propagate work that leads to expand our knowledge in molecular mechanism, diagnosis, treatment, and prevention of hepatocellular carcinoma. Studies applying systems biology with integrated multi-omics studies are also welcome. Article types to be considered are: Original Research, Review, Mini Review and Case Report.

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Nimmi Anna
Journal Manager
Allied Journal of Medical Research
Email: medicalresearch@emedsci.com
https://www.alliedacademies.org/allied-journal-of-medical-research/